Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPA1 | O75762 | 2/20 | 0.50 |
| ▸ | ATM | Q13315 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.43 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 2/20 | 0.38 |
| ▸ | ACHE | P22303 | 1/20 | 0.38 |
| ▸ | CA2 | P00918 | 2/20 | 0.38 |
| ▸ | CA1 | P00915 | 1/20 | 0.38 |
| ▸ | CA7 | P43166 | 1/20 | 0.38 |
| ▸ | CA9 | Q16790 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 2/20 | 0.35 |
| ▸ | LPL | P06858 | 1/20 | 0.35 |
| ▸ | LIPG | Q9Y5X9 | 1/20 | 0.35 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.34 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29479067 | 1.00 | TRPA1 (0.50) | TRPA1ATMALDH1A1ENPP2CYP1A2 | |
| SCHEMBL28220679 | 0.97 | TRPA1 (0.48) | TRPA1ATMALDH1A1ENPP2CYP1A2 | |
| SCHEMBL28686816 | 0.87 | TRPA1 (0.40) | TRPA1ATMALDH1A1ENPP2CYP1A2 | |
| SCHEMBL12270904 | 0.85 | TRPA1 (0.46) | TRPA1ATMALDH1A1CYP1A2CYP2A6 | |
| SCHEMBL30314457 | 0.81 | TRPA1 (0.46) | TRPA1ATMALDH1A1CYP1A2CYP2A6 | |
| SCHEMBL8596451 | 0.81 | TRPA1 (0.46) | TRPA1ATMALDH1A1CYP1A2CYP2A6 | |
| SCHEMBL18576541 | 0.80 | ENPP2 (0.38) | TRPA1ATMALDH1A1ENPP2TSHR | |
| SCHEMBL29951003 | 0.80 | TRPA1 (0.41) | TRPA1ATMALDH1A1ENPP2TSHR | |
| SCHEMBL9109699 | 0.79 | TRPA1 (0.44) | TRPA1ATMALDH1A1CYP1A2CYP2A6 | |
| SCHEMBL3783711 | 0.78 | TRPA1 (0.40) | TRPA1ATMALDH1A1ENPP2CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 752 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250194617-A1 | Materials and Methods for Extending Shelf-Life of Foods | JP LABORATORIES, INC. | 2025-06-19 | — | — | US | claimed |
| US-20250169514-A1 | Materials and Methods for Extending Shelf-Life of Foods | JP LABORATORIES, INC. | 2025-05-29 | — | — | US | claimed |
| US-12188898-B2 | Non-enzymatic electrochemical sensor for measuring analytes | TERUMO KABUSHIKI KAISHA (JP) | 2025-01-07 | — | — | US | claimed |
| CN-117866306-A | Tough natural epoxy rubber elastomer and preparation method thereof | 贺州学院 | 2024-04-12 | — | — | CN | claimed |
| US-20240019396-A1 | NON-ENZYMATIC ELECTROCHEMICAL SENSOR FOR MEASURING ANALYTES | TERUMO KABUSHIKI KAISHA (JP) | 2024-01-18 | — | — | US | claimed |
| US-20230380457-A1 | Materials and Methods for Extending Shelf-Life of Foods | JP LABORATORIES, INC. | 2023-11-30 | — | — | US | claimed |
| EP-4280882-A2 | MATERIALS AND METHODS FOR EXTENDING SHELF-LIFE OF FOODS | JP LABORATORIES, INC. (US) | 2023-11-29 | — | — | EP | claimed |
| US-20230363426-A1 | Materials and Methods for Extending Shelf-Life of Foods | JP LABORATORIES, INC. | 2023-11-16 | — | — | US | claimed |
| US-11793220-B2 | Materials and methods for extending shelf-life of foods | JP LABORATORIES, INC. (US) | 2023-10-24 | — | — | US | claimed |
| CN-116916755-A | Materials and methods for extending the shelf life of food products | JP实验室公司 | 2023-10-20 | — | — | CN | claimed |
| EP-2059227-A2 | POLYMER SYSTEMS FOR LUNG VOLUME REDUCTION THERAPY | Aeris Therapeutics, Inc. (US) | 2009-05-20 | — | — | EP | claimed |
| US-7381849-B1 | Synthesis of asymmetric tetracarboxylic acids and dianhydrides | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) | 2008-06-03 | — | — | US | claimed |
| WO-2008039827-A2 | POLYMER SYSTEMS FOR LUNG VOLUME REDUCTION THERAPY | AERIS THERAPEUTICS, INC. (US) | 2008-04-03 | — | — | WO | claimed |
| EP-0626016-B1 | CHEMILUMINESCENT ENHANCERS | BRITISH TECH GROUP (GB) | 1998-06-03 | — | — | EP | claimed |
| EP-0692033-B1 | ENHANCEMENT OF CHEMILUMINESCENT REACTIONS | BRITISH TECH GROUP (GB) | 1998-03-11 | — | — | EP | claimed |
| US-5629168-A | Chemiluminescent enhancers | BRITISH TECHNOLOGY GROUP LIMITED (GB) | 1997-05-13 | — | — | US | claimed |
| US-5512451-A | MIXTURE OF A AROMATIC DIACYL CYCLIC HYDRAZIDE, PEROXIDASE CATALYST AND OXIDIZER | BRITISH TECHNOLOGY GROUP LIMITED (GB) | 1996-04-30 | — | — | US | claimed |
| EP-0692033-A1 | ENHANCEMENT OF CHEMILUMINESCENT REACTIONS | BTG INTERNATIONAL LIMITED (GB) | 1996-01-17 | — | — | EP | claimed |
| WO-1994023060-A2 | ENHANCEMENT OF CHEMILUMINESCENT REACTIONS | BRITISH TECHNOLOGY GROUP LIMITED (GB) | 1994-10-13 | — | — | WO | claimed |
| WO-1993016195-A1 | CHEMILUMINESCENT ENHANCERS | BRITISH TECHNOLOGY GROUP LTD. (GB) | 1993-08-19 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240019396-A1 | NON-ENZYMATIC ELECTROCHEMICAL SENSOR FOR MEASURING ANALYTES | SPR, SRR, BLVRB | TRPA1 3307/4885ATM 4374/4885ALDH1A1 1305/4885 |
| US-12188898-B2 | Non-enzymatic electrochemical sensor for measuring analytes | SPR, SRR, BLVRB | TRPA1 3307/4885ATM 4374/4885ALDH1A1 1305/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.